Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Previous close
$2.335
+$0.035 · +1.52%
Regular session · ET · Market data may be delayed.
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Day range
Current $2.335
52-week range
Current $2.335
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
33
Expensive
Sentiment
56
Mixed
Risk
65
High Risk
Momentum
24
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Day range
Current $2.335
52-week range
Current $2.335
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 21.05M USD | 100.56M USD | 97.06M USD | 133.62M USD | 207.09M USD |
| Cost of goods sold | 9.66M USD | 185.94M USD | 8.85M USD | — | 189.41M USD |
| Gross profit | 11.38M USD | −85.38M USD | 88.21M USD | 133.62M USD | 17.68M USD |
| Research and development | 123.07M USD | 209.24M USD | 192.12M USD | 210.42M USD | 189.41M USD |
| Selling, general, and administrative | 53.99M USD | 57.41M USD | 56.69M USD | 61.03M USD | 55.04M USD |
| Operating expenses | 157.19M USD | 59.62M USD | 239.95M USD | 271.45M USD | 55.04M USD |
| Depreciation and amortization | 9.66M USD | 8.84M USD | 8.85M USD | 8.47M USD | 8.32M USD |
| Operating income | −145.81M USD | −145M USD | −151.74M USD | −137.83M USD | −37.36M USD |
| Net income | −142.93M USD | −119.05M USD | −130.39M USD | −133.31M USD | −36.33M USD |
Company facts updated Nov 22, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$3.83
64.03% upsideFunds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM6.12M0.01%71.54B USD0.19%$256.61-2.88%
Vanguard Morningstar Total Stock Market ETFVTI4.94M0.00%689.3B USD0.03%$340.02-3.52%
Vanguard Extended Market ETFVXF2.37M0.00%30.2B USD0.05%$211.44-3.21%
iShares Russell 2000 Growth ETFIWO1.91M0.01%12.73B USD0.24%$320.43-3.57%
Vanguard Russell 2000 ETFVTWO1.21M0.01%16.8B USD0.06%$103.76-2.76%
Schwab U.S. Small-Cap ETFSCHA1.14M0.01%20.45B USD0.03%$30.51-2.83%
iShares Micro-Cap ETFIWC659.86K0.06%1.09B USD0.60%$157.87-3.19%
Vanguard Health Care ETFVHT650.95K0.00%20.8B USD0.09%$326.69-0.40%
iShares Russell 2000 ETFIWM
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
Vanguard Russell 2000 ETFVTWO
Schwab U.S. Small-Cap ETFSCHA
iShares Micro-Cap ETFIWC
Vanguard Health Care ETFVHTAI-generated and delayed market data for informational and educational purposes only. Not investment advice.